Latham & Watkins advised Invetx on the deal. Invetx, a pioneer in protein-based therapeutics for animal health, has announced that it has raised US$60.5 million in...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here